NAD+ and Cellular Energy: The Evidence

NAD+ has become one of the most discussed molecules in the wellness category, and for once the popular interest tracks a genuine scientific story. The basic biology is well established and well cited. The trouble, as always, is the distance between the foundational cell biology and the marketing claims that get attached to it. This article walks through what the published research describes about NAD+ and cellular energy, what is settled, and what is still being worked out, so providers can speak to it accurately.

What NAD+ Is and Why It Matters

Nicotinamide adenine dinucleotide, abbreviated NAD+, is a coenzyme present in every living cell. Its central role in metabolism is not controversial: NAD+ is essential for the redox reactions that convert nutrients into cellular energy, shuttling electrons through the pathways that ultimately produce ATP. In a comprehensive 2021 review in Nature Reviews Molecular Cell Biology, the authors describe NAD+ as a coenzyme central to metabolism that also serves as a substrate for enzymes that govern fundamental cellular processes.¹ In other words, NAD+ is not a fringe supplement ingredient with a speculative mechanism. It is a coenzyme that textbook biochemistry has treated as essential for a very long time.

Beyond its classic role in energy metabolism, NAD+ is consumed as a substrate by several families of signaling enzymes, including the sirtuins and the PARPs. A 2015 review in Science framed NAD+ as a molecule sitting at the intersection of metabolism, aging, and neurodegeneration, precisely because these NAD+-consuming enzymes link the cell's energy state to its repair and survival programs.² This dual identity, both an energy coenzyme and a signaling substrate, is what makes NAD+ scientifically interesting and also what makes it prone to overstatement.

The Aging Connection

The aspect of NAD+ that drives most patient interest is its relationship to aging. Here the research is real but should be described carefully. The published literature reports that cellular NAD+ levels decline with age across multiple tissues, and reviews have connected this decline to the broader hallmarks of aging. A 2024 review in Cold Spring Harbor Perspectives in Medicine summarizes the roles of NAD+ in health and aging and discusses how age-associated NAD+ decline relates to physiological function, while treating therapeutic NAD+ repletion as an active and still-developing area of investigation rather than a settled clinical intervention.³

The accurate framing for a patient conversation is this: the observation that NAD+ declines with age is well documented, and the hypothesis that supporting NAD+ levels could influence aspects of cellular function is a serious and active area of research. That is different from saying that any NAD+ product reverses aging or restores youthful energy. The first statement describes science. The second is a claim the evidence does not support and that no provider should make.

NAD+ and Cellular Energy: The Honest Version

It is biochemically correct that NAD+ is required for cellular energy production. It does not follow that taking an NAD+ precursor will make a given patient feel more energetic, and that is the exact place where careful language matters. "Cellular energy" in the biochemical sense, electron transfer and ATP synthesis, is not the same thing as the subjective experience of energy a patient is hoping for. Conflating the two is the most common overclaim in this category.

The defensible mechanistic statement is that NAD+ is essential to the metabolic pathways that generate cellular energy, and that the research community is actively studying whether and how supporting NAD+ status translates into measurable functional outcomes in humans.¹³ The honest caveat is that human outcome data are still developing, that effects vary by individual and context, and that you cannot promise a patient will feel different. It is also worth noting that the way NAD+ status is supported matters: most human work has studied NAD+ precursors rather than NAD+ itself, because the precursor and the coenzyme are handled differently by the body. A claim built on precursor research should not be silently transferred to a different compound or format, and a precise provider keeps track of exactly which molecule a given study examined before repeating its conclusions.

Sirtuins, PARPs, and Why the Mechanism Is Compelling

To understand why NAD+ attracts serious scientific attention rather than just marketing attention, it helps to look at what consumes it. Beyond its role as an electron carrier in energy metabolism, NAD+ is the required substrate for several families of enzymes that regulate how cells respond to stress and damage. The sirtuins, a family of enzymes implicated in metabolic regulation and cellular maintenance, depend on NAD+ to function. The PARP enzymes, central to DNA-damage responses, also consume NAD+. Because these enzymes draw on the same NAD+ pool that energy metabolism uses, the cell's NAD+ status effectively links its energy state to its repair and signaling programs.²

This is the mechanistic heart of the NAD+ aging hypothesis. If NAD+ declines with age, the reasoning goes, then the enzymes that depend on it may operate less effectively, which could contribute to the functional changes associated with aging. The published reviews treat this as a coherent and well-motivated hypothesis, supported by substantial cell and animal biology, while being clear that demonstrating meaningful clinical benefit from NAD+ repletion in humans is a separate and still-developing question.¹³ The mechanism is genuinely compelling. That is different from saying the clinical case is closed, and a careful provider holds both ideas at once.

The Delivery Question

NAD+ and its precursors are notoriously difficult to deliver, which is why the delivery format is a substantive question rather than a marketing footnote. NAD+ itself is a large, polar molecule, and the route by which it or its precursors are administered affects how the body handles it. Clinics most often encounter this question as a comparison between intravenous NAD+ and other formats. The bioavailability and operational tradeoffs between an IV protocol and an oral dissolving strip are covered in detail in NAD+ strips vs. NAD+ IV, and the underlying route-of-delivery science is in sublingual vs injectable bioavailability. The key point for this article is that the molecule's biology and the delivery format are two separate questions, and both deserve accurate treatment.

How to Talk About NAD+ With Patients

• Lead with the settled biology. NAD+ is a coenzyme essential for cellular energy metabolism. That is textbook, not hype.¹
• Describe the aging link as an association under study. NAD+ declines with age; therapeutic repletion is an active research area, not a proven anti-aging treatment.³
• Separate biochemical energy from felt energy. Required for ATP production is not the same as a promise that the patient will feel more energetic.
• Do not imply approval or guaranteed outcomes. Stay within your scope and applicable regulations, and avoid disease claims.

The Bottom Line for Practices

NAD+ is one of the rare wellness-category molecules with a deep, credible foundation in mainstream cell biology. Its role in cellular energy metabolism is established, its decline with age is documented, and its connection to signaling pathways involved in aging is an active, legitimate research frontier.¹²³ The opportunity for providers is to meet patient curiosity with accurate science rather than inflated promises. In a category crowded with overstatement, the practice that explains NAD+ correctly is the one patients come to trust.

The oral dissolving strips in our wholesale program use patented InstaRelease® technology by InstaMed. To evaluate the format for your practice, apply for a free wholesale account.

References

1. Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol. 2021;22(2):119-141. PubMed: 33353981
2. Verdin E. NAD+ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213. PubMed: 26785480
3. Lautrup S, Hou Y, Fang EF, Bohr VA. Roles of NAD+ in Health and Aging. Cold Spring Harb Perspect Med. 2024;14(1):a041193. PubMed: 37848251

Disclaimer: This article is for educational purposes for healthcare providers and is not medical advice. Statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. NAD+ research on human functional outcomes is still developing, and effects vary by individual. Providers are responsible for evaluating products and clinical use within their own scope of practice and applicable regulations.